Fast-food giants continue to expand in China

Even though China’s economic growth as slowed lately, these two fast-food giants continue to expand in that country. We feel these investments will ultimately pay off, which will let them keep raising their dividends.
STARBUCKS CORP. $75 is a buy for aggressive investors. The company (Nasdaq symbol SBUX;… Read More

embecta has better rebound potential

These two firms have struggled since being spun off by larger medical firms. While both are taking steps to improve their product lineups, we feel embecta is in a better position to rebound from its recent drop.
VIATRIS INC. $12 is a hold. The company (New York symbol… Read More

High debt loads hold them back

In the past few years, big pharmaceutical companies have spun off their consumer drug operations. That’s part of their strategy to focus on more-profitable prescription drug businesses. These two recent spinoffs have decent long-term prospects, but their shares will likely remain depressed until they cut… Read More

Cannabis Corner: Keep an eye on these industry stocks

Canada legalized cannabis over four years ago. While demand has been steady, stiff competition has cut selling prices significantly. Meanwhile, advertising restrictions and plain packaging rules make it hard to build brands that win customer loyalty. Still, we think some companies have a distinct edge—including… Read More